CompletedNCT01391637
Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)
Studying Pelizaeus-Merzbacher disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- StemCells, Inc.
- Principal Investigator
- Stephen Huhn, MDStemCells, Inc.
- Intervention
- HuCNS-SC transplant in the lead-in phase(biological)
- Enrollment
- 4 enrolled
- Eligibility
- MALE
- Timeline
- 2011 – 2016
Study locations (1)
- UCSF Medical Center, San Francisco, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01391637 on ClinicalTrials.govOther trials for Pelizaeus-Merzbacher disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06150716Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)Ionis Pharmaceuticals, Inc.
- RECRUITINGNCT05659901Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher DiseaseIonis Pharmaceuticals, Inc.